We describe here the evaluation of the reformatted test device to investigate the accuracy of the measles IgM RDT for surveillance, using sera from a representative panel of suspected cases sent for measles investigation or confirmation to the WHO Measles Regional and National Reference Laboratory in Rio de Janeiro. This evidence concerns the gene CD40LG and measles.